Get the Stockscreener App
14.18
6.46%
0.86
After Hours:
13.02
-1.16
-8.18%
Apollomics Inc stock is traded at $14.18, with a volume of 25,622.
It is up +6.46% in the last 24 hours and down -23.07% over the past month.
Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.
See More
Previous Close:
$13.32
Open:
$12.5
24h Volume:
25,622
Relative Volume:
0.36
Market Cap:
$15.65M
Revenue:
-
Net Income/Loss:
$-53.86M
P/E Ratio:
-0.2603
EPS:
-54.4704
Net Cash Flow:
$-28.76M
1W Performance:
+1.50%
1M Performance:
-23.07%
6M Performance:
+144.06%
1Y Performance:
+11.57%
1-Day Range:
$12.50
$14.95
1-Week Range:
$11.30
$15.80
52-Week Range:
$3.659
$42.12
Apollomics Inc Stock (APLM) Company Profile
Compare APLM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APLM
Apollomics Inc
|
14.18 | 28.55M | 0 | -53.86M | -28.76M | -54.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Apollomics Inc Stock (APLM) Latest News
How Apollomics Inc. Equity Warrant stock reacts to bond yieldsShare Buyback & Free Verified High Yield Trade Plans - newser.com
Apollomics Inc. Equity Warrant stock trendline breakdown2025 Breakouts & Breakdowns & Technical Confirmation Alerts - newser.com
How strong is Apollomics Inc. Equity Warrant stock revenue growthTrade Risk Assessment & Daily Volume Surge Signals - newser.com
Can Apollomics Inc. Equity Warrant stock resist sector downturnsBuy Signal & Accurate Buy Signal Notifications - newser.com
Applying Elliott Wave Theory to Apollomics Inc.July 2025 Review & Comprehensive Market Scan Reports - newser.com
Is Apollomics Inc. Equity Warrant stock a top momentum playWall Street Watch & Free Daily Entry Point Trade Alerts - newser.com
Building trade automation scripts for Apollomics Inc.July 2025 Sentiment & Community Trade Idea Sharing - newser.com
Is Apollomics Inc. stock attractive for hedge fundsPortfolio Gains Report & Weekly Stock Performance Updates - newser.com
Published on: 2025-11-06 12:31:23 - newser.com
Why Apollomics Inc. Equity Warrant stock is popular among millennialsJuly 2025 PostEarnings & Risk Managed Investment Entry Signals - newser.com
Apollomics Inc. Equity Warrant recovery potential after sell offMarket Trend Review & Expert-Curated Trade Recommendations - newser.com
Apollomics Inc. Equity Warrant’s volatility index tracking explainedJuly 2025 Snapshot & High Accuracy Trade Alerts - newser.com
Volume spikes in Apollomics Inc. Equity Warrant stock – what they meanPortfolio Risk Report & Safe Entry Trade Signal Reports - newser.com
Exit strategy if you’re trapped in Apollomics Inc. Equity WarrantWeekly Market Summary & Weekly High Return Opportunities - newser.com
How Apollomics Inc. stock compares to market leadersMarket Performance Summary & Proven Capital Preservation Tips - newser.com
Will Apollomics Inc. stock split again soonJuly 2025 Weekly Recap & High Return Trade Guides - fcp.pa.gov.br
Sentiment analysis tools applied to Apollomics Inc.2025 Support & Resistance & Free Fast Gain Swing Trade Alerts - newser.com
Can Apollomics Inc. stock deliver consistent earnings growthJuly 2025 Recap & Smart Investment Allocation Insights - fcp.pa.gov.br
How Apollomics Inc. stock valuations compare to rivalsQuarterly Earnings Report & Community Verified Trade Signals - fcp.pa.gov.br
Is Apollomics Inc. Equity Warrant a candidate for recovery playWeekly Gains Report & High Accuracy Trade Signal Alerts - newser.com
What Fibonacci levels say about Apollomics Inc. rebound2025 Institutional Moves & AI Powered Buy and Sell Recommendations - newser.com
Is Apollomics Inc. stock positioned for long term growthJuly 2025 Weekly Recap & Real-Time Chart Pattern Alerts - newser.com
Can Apollomics Inc. Equity Warrant stock double in next 5 yearsGold Moves & Low Volatility Stock Suggestions - fcp.pa.gov.br
Published on: 2025-11-05 07:31:22 - newser.com
Can Apollomics Inc. stock attract ESG capital inflowsMarket Sentiment Report & Precise Trade Entry Recommendations - fcp.pa.gov.br
Published on: 2025-11-05 04:35:01 - newser.com
Volume spikes in Apollomics Inc. stock – what they meanTrade Risk Summary & Fast Moving Stock Watchlists - newser.com
Can Apollomics Inc. stock continue upward trendJuly 2025 Update & Short-Term Swing Trade Alerts - newser.com
Full technical analysis of Apollomics Inc. Equity Warrant stockJuly 2025 WrapUp & AI Enhanced Trading Signals - newser.com
Published on: 2025-11-04 04:30:39 - newser.com
Published on: 2025-11-04 04:21:41 - newser.com
Leading vs lagging indicators on Apollomics Inc. Equity Warrant performanceWeekly Gains Summary & AI Forecast for Swing Trade Picks - newser.com
Apollomics Inc Stock (APLM) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.44%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):